Skip to contentSkip to footer
employer cover photo
employer logo
employer logo

Agios Pharmaceuticals

Engaged Employer

Agios Pharmaceuticals reviews

Churn has put the glory days in the past - Anonymous employee Agios Pharmaceuticals Employee Review

3.0
Sep 13, 2017
Anonymous employee
Recommend
CEO approval
Business Outlook

Pros

Much about the culture is fantastic. The CEO, David Schenkein, is one of the best things about the company in a lot of ways. His care for and commitment to patients is extremely palpable. The idea upon which the company is based, cancer metabolism, was also not a bad one although it's debatable whether a real cancer metabolism drug will ever come out of Agios. Patients are being helped regardless of the pathway with the approval of IDH drugs though and that's what matters.

Cons

Upper management long ago gave up on removing poor leaders. The place is littered with marginal management (centered around director level) that don't live up to the Agios hype and don't direct the company in any meaningful way. There are some stars in this class and these are the rare directors that have risen through the ranks and not left the company for greener pastures but unfortunately they are the minority. My greatest fear is that Agios will be another Amgen coasting off an early success that is largely driven by some early hard work and good luck with IDH (and maybe from the clever repositioning of early PKD drugs) but will flounder for years with the vacuum created by most of the early leaders and pioneers having departed. Fingers crossed that I'm wrong and things will somehow look up.

avatar
Agios Pharmaceuticals Response
8y
Thank you for taking the time to provide your insights. I am glad that during your time at Agios our mission of getting medicines to the patients who need them resonated with you. As a company, we are constantly working to develop our leaders and to ensure that our managers are able to lead in the best way possible. We would love to hear more from you to further understand the context of your feedback and to be able to have a dialogue around your concerns. If you would like to touch base, please reach out to me directly to connect. - SVP, HR

Explore other reviews about Agios Pharmaceuticals

5.0
May 7, 2026
Associate director in r&d
Recommend
CEO approval
Business Outlook

Pros

Work life balance, benefits, and compensation. Great community and caring staff.

Cons

Resources can be slim, but that is also true in our industry currently.

3.0
Apr 12, 2026
Director
Recommend
CEO approval
Business Outlook

Pros

The company has a clear and compelling mission, and the underlying science is strong. The organization is small enough to offer visibility into important work and the ability to contribute meaningfully. There are opportunities to engage across functions and support high-impact initiatives tied to data dissemination and external engagement. Colleagues are generally capable and collaborative, and compensation is competitive relative to the market.

Cons

The work environment can be highly reactive, with frequent shifts in priorities and limited long-term strategy. This can create unnecessary urgency and reduce efficiency. Organizational changes have led to some inconsistency in direction and execution. Communication from senior leadership is not always clear, which can result in duplicated effort or last-minute changes. Internal alignment can take longer than expected, slowing progress. Work-life balance is not great, due to volume of work and frequent pivoting.

1
See reviews by: Helpful|Rating|Date|All
Related searches: Agios Pharmaceuticals jobs | Agios Pharmaceuticals salaries | Agios Pharmaceuticals benefits | Agios Pharmaceuticals interviews
Agios Pharmaceuticals reviewsAgios Pharmaceuticals review